Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1981 1
1987 1
1988 1
1990 1
1991 1
1992 1
1996 1
2001 1
2005 2
2006 4
2007 8
2008 6
2009 4
2010 16
2011 10
2012 14
2013 9
2014 20
2015 24
2016 19
2017 23
2018 22
2019 22
2020 25
2021 31
2022 20
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
HER3 in cancer: from the bench to the bedside.
Gandullo-Sánchez L, Ocaña A, Pandiella A. Gandullo-Sánchez L, et al. Among authors: ocana a. J Exp Clin Cancer Res. 2022 Oct 21;41(1):310. doi: 10.1186/s13046-022-02515-x. J Exp Clin Cancer Res. 2022. PMID: 36271429 Free PMC article. Review.
Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients.
Herrera M, Berral-González A, López-Cade I, Galindo-Pumariño C, Bueno-Fortes S, Martín-Merino M, Carrato A, Ocaña A, De La Pinta C, López-Alfonso A, Peña C, García-Barberán V, De Las Rivas J. Herrera M, et al. Among authors: ocana a. Mol Cancer. 2021 Apr 29;20(1):73. doi: 10.1186/s12943-021-01367-x. Mol Cancer. 2021. PMID: 33926453 Free PMC article. No abstract available.
Clinical considerations for the design of PROTACs in cancer.
Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Nieto-Jiménez C, et al. Among authors: ocana a. Mol Cancer. 2022 Mar 7;21(1):67. doi: 10.1186/s12943-022-01535-7. Mol Cancer. 2022. PMID: 35249548 Free PMC article. Review.
Resistance to Antibody-Drug Conjugates.
García-Alonso S, Ocaña A, Pandiella A. García-Alonso S, et al. Among authors: ocana a. Cancer Res. 2018 May 1;78(9):2159-2165. doi: 10.1158/0008-5472.CAN-17-3671. Epub 2018 Apr 13. Cancer Res. 2018. PMID: 29653942 Review.
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Noblejas-López MDM, Gandullo-Sánchez L, Galán-Moya EM, López-Rosa R, Tébar-García D, Nieto-Jiménez C, Gómez-Juárez M, Burgos M, Pandiella A, Ocaña A. Noblejas-López MDM, et al. Among authors: ocana a. Int J Mol Sci. 2022 May 13;23(10):5476. doi: 10.3390/ijms23105476. Int J Mol Sci. 2022. PMID: 35628286 Free PMC article.
277 results